In recent years, glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have emerged as effective therapeutic agents, as they stimulate insulin secretion and suppress glucagon release in a glucose-dependent manner, thereby improving glycemic control with a low risk of hypoglycemia [2]
EDC-2: the Endocrine Societys second scientific statement on endocrine-disrupting chemicals
These side effects often follow a pattern, with symptoms frequently occurring after injections and during dose increases
The absence of human clinical data means every individual is essentially running an n=1 experiment
It assists the fat metabolism and the process of energy formation, along with many other processes
You can't ignore their effects on your heart, possible drug interactions, impacts on your brain, and stress on your liver and kidneys